| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.42B | 12.33B | 11.87B | 10.93B | 10.46B |
| Gross Profit | 3.80B | 4.53B | 4.44B | 4.02B | 3.75B |
| EBITDA | 1.36B | 1.63B | 1.87B | 1.67B | 1.62B |
| Net Income | 1.53B | 1.54B | 1.58B | 1.40B | 1.31B |
Balance Sheet | |||||
| Total Assets | 23.46B | 22.90B | 21.79B | 20.65B | 18.77B |
| Cash, Cash Equivalents and Short-Term Investments | 8.82B | 9.18B | 9.53B | 8.03B | 6.04B |
| Total Debt | 357.29M | 266.80M | 277.23M | 424.16M | 304.88M |
| Total Liabilities | 7.72B | 7.89B | 8.37B | 7.99B | 7.66B |
| Stockholders Equity | 15.27B | 14.61B | 13.07B | 12.49B | 11.22B |
Cash Flow | |||||
| Free Cash Flow | 1.40B | 1.62B | 2.17B | 1.81B | 1.77B |
| Operating Cash Flow | 1.58B | 1.77B | 2.35B | 2.02B | 2.05B |
| Investing Cash Flow | -2.34B | -822.95M | -460.95M | 232.44M | -1.28B |
| Financing Cash Flow | -873.59M | -1.07B | -575.82M | -492.51M | -511.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$17.85B | 7.43 | 10.42% | 6.34% | -4.65% | 6.30% | |
67 Neutral | HK$28.05B | -39.92 | -4.08% | ― | -10.26% | -85.75% | |
65 Neutral | HK$23.41B | 48.66 | 24.66% | ― | 43.92% | -196.81% | |
61 Neutral | HK$1.34B | 4.01 | 7.55% | 5.71% | 0.59% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
47 Neutral | HK$6.96B | 13.03 | 6.13% | 4.71% | -7.61% | -90.51% | |
40 Underperform | HK$826.94M | 9.19 | -39.25% | ― | 309.32% | -205.04% |